Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9874798Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$3.7M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#2,341
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Manesh R Patel as a PI. Multi-PI records show the full award amount for context.
- 5UH3HL165017-03UH31/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)$1.9Maward amount
- 4UH3HL171357-02UH31/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)$1.8Maward amount
- 3UH3HL165017-03S1UH31/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)$5.4Kaward amount
- 3UH3HL165017-03S2UH31/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)$5.4Kaward amount
Award organization
Organizations that administered FY2025 awards listing Manesh R Patel as a PI.
FY2025 award administered by Duke University (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDuke University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1269
- 2024Entered Top 25% NationallyRanked #1269
- 2024Entered Top 10% NationallyRanked #1269
- 2025$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Manesh R Patel.